Improving Lives Through Science
› Resources › Novel Therapies Using Stem Cells
Stem cells, sometimes colloquially referred to as master cells, have the ability to self-renew and give rise to a range of other cells. These cells are essential for tissue maintenance and injury repair, and act as the building blocks for our tissues and organs. Due to their impressive nature, research around using stem cells for regenerative medicine has rapidly increased in recent years.
There are two main types of stem cells: embryonic stem cells and adult stem cells.
Embryonic stem cells come from the remaining unused embryos during the in vitro fertilization process. They are pluripotent and highly versatile. However, their application and use in modern medicine has raised several ethical concerns due to how they are sourced. Embryonic stem cells also pose a higher risk of tumor formation and immune rejection due to the foreign nature of their genetic formation.
On the other hand, adult stem cells are isolated from fully-developed tissues. The most common example is mesenchymal stem cells, which are isolated from bone marrow, adipose or connective tissues, and umbilical cord blood. While they are easier to find in certain adult tissues, they have limitations on how they can be used for medical treatments since they are not pluripotent and can only differentiate into a minimal range of cell types such as bone, cartilage, muscle, and fat cells. Adult stem cells are also prone to irregularities that come from environmental hazards, hence the requirement for ideal conditions to support their culture. The ever-increasing body of research surrounding therapeutic applications of mesenchymal stem cells offers a glimpse into the promising future of cell therapy.
Stem cell-based therapies are at the center of modern research as the next chapter of regenerative medicine, replacing more conventional methods like organ transplantation, which has limited supply, and promoting better body-repair machinery. In pathology research, in-depth studies about stem cells and their applications allow for a comprehensive understanding of how diseases begin by watching their maturing.
Mesenchymal stem cells (MSCs) offer promising therapeutic potential for a diverse range of diseases, including cardiovascular and liver disorders, arthritis, and cancer.
While current MSC therapies are considered safe, their efficacy is still questionable for treatment of cardiovascular disease. Clinical trials, even those at the phase III level, have not demonstrated significant improvements in overall clinical outcomes. Meta-analysis also shows that MSCs have not enhanced myocardial contractility or cardiovascular remodeling. These results may be caused by the immunomodulatory effects of the stem cells as opposed to the desired regenerative effects. Issues such as optimal cell sourcing, dosage, delivery methods, timing, and mechanisms of actions should be addressed in the future, along with well-designed and randomized clinical trials.
Stem cell-based therapies for liver diseases are also currently being explored as alternatives for organ transplantation. While short-term outcomes in liver regeneration and function seem promising for the treatment of liver failure, the prolonged effects require more observation. As for autoimmune liver diseases (ALD), there have been some reports of successful bone marrow transplantation to induce remission.
Meanwhile, arthritis patients, specifically those with osteoarthritis which involves the degeneration of articular cartilage, often suffer from the painful and lengthy aftermath of traditional treatments. MSC therapies have demonstrated a potential to alleviate pain, reduce cartilage degeneration, and facilitate cartilage repair.
Finally, the complex field of oncology also may reap the benefits of stem cell-based therapies. For MSCs specifically, the impact of both their protumor and antitumor properties are still rigorously examined, as several preclinical studies suggest how they might promote tumor growth, whereas others indicate their potential in fighting tumors while still sparing healthy tissues.
Simultaneously with these optimistic medical findings, more careful and studious trials need to take place to establish ideal conditions of MSC-based treatments. On top of that, to ensure safety, precision and optimal growth conditions in stem cell research, integrating advanced lab equipment is essential. Equipment such as the Labculture® G4 Class II Type A2 Biological Safety Cabinet (BSC) allows an environment free of contaminants, and extended work periods supported by its ergonomic design for safety and ease of use. While the CelCulture® CO₂ Incubator with its uniform heating and robust contamination control supports the growth of stem cell cultures. Together they offer increased potential success and minimized risk in stem cell research.
LA2-4S9 G4
The Labculture® G4 Class II Type A2 Biological Safety Cabinet (BSC) ensures safety and contamination control for the vulnerable and volatile nature of stem cell research, and provides an ergonomic work zone for extended work periods as well as bright illumination for precise handling. It is versatile with three different sash height openings (8”, 10”, and 12”) and supports advanced control and monitoring that is just right for the field.
Features:
Centurion Touchscreen Controller
Dimmable LED
Ergonomic Sash
Tray support beams and holder
USB Port and Remote Modbus
Cabinet Construction
Green Product
ULPA Filter
*99.999% at 0.1 to 0.3 micron, ULPA as per IEST-RP-CC001.3 USA
*99.999% at MPPS, H14 as per EN 1822 EU
Isocide™ Antimicrobial Powder Coating
CCL-B
The CelCulture® CO₂ Incubator supports the optimal growth and differentiation environment for stem cell cultures and protects them against contamination for increased experiment success. The reliable design and performance minimizes risk of error and eases operation.
Features:
Robust Contamination Control
Direct Heat and Air Jacket
Shelving
Rounded Corners
CO2 Sensor
Isocide™ Antimicrobial Powder Coating
CelCulture® CO2 Incubators | Esco Scientific. https://www.escolifesciences.com/products/co2-incubator/celculture-co2-incubator
Hoang, et al. (2022). Stem cell-based therapy for human diseases. Signal Transduction and Targeted Therapy, 7(1), 1-41. https://doi.org/10.1038/s41392-022-01134-4
Labculture® G4 Class II Type A2 BSC | Esco Lifesciences. https://www.escolifesciences.com/products/class-ii-biological-safety-cabinet/labculture-g4-class-ii-type-a2-biological-safety-cabinet
Mayo Clinic (2022). Stem cells: What they are and what they do. Mayo Foundation for Medical Education and Research. https://www.mayoclinic.org/tests-procedures/bone-marrow-transplant/in-depth/stem-cells/art-20048117
Stanford Children's Health. (2019). What are stem cells? Stanfordchildrens.org; Stanford Medicine. https://www.stanfordchildrens.org/en/topic/default?id=what-are-stem-cells-160-38